Filing Details
Gossamer Bio, Inc. (NASDAQ:GOSS) filed a Form 8-K with the Securities and Exchange Commission on July 01, 2026, disclosing a material event.
8k filedNASDAQ:GOSS
Gossamer Bio, Inc. (GOSS) Reports Material Event to SEC
Filing Details Gossamer Bio, Inc. (NASDAQ:GOSS) filed a Form 8-K with the Securities and Exchange Commission on July 01, 2026, disclosing a material event. Market Context Gossamer…
Market Context
Gossamer Bio, Inc.'s stock currently trades at $0.17 with a market capitalization of $824.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Gossamer Bio, Inc.'s stock.
All SEC filings for Gossamer Bio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GOSS Stock Page
Frequently Asked Questions
Where can I read GOSS's SEC filings?
Browse all filings on our GOSS SEC filings page.
What types of SEC filings does Gossamer Bio, Inc. file?
Public companies like Gossamer Bio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.